Investors Capital Advisory Services’s Biogen BIIB Stock Holding History

Investors Capital Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-780	Closed	-$238K	–	703
2015 Q4	$238K	Sell	780 -1,534	-66%	-$441K	0.05%	515
2015 Q3	$674K	Buy	2,314 +134	+6%	+$44.3K	0.14%	217
2015 Q2	$879K	Sell	2,180 -472	-18%	-$189K	0.16%	177
2015 Q1	$1.12M	Buy	2,652 +88	+3%	+$34.7K	0.21%	130
2014 Q4	$869K	Buy	2,564 +199	+8%	+$64.4K	0.17%	179
2014 Q3	$781K	Sell	2,365 -625	-21%	-$206K	0.15%	195
2014 Q2	$941K	Buy	2,990 +145	+5%	+$43.6K	0.15%	211
2014 Q1	$868K	Sell	2,845 -55	-2%	-$17.5K	0.19%	160
2013 Q4	$809K	Sell	2,900 -113	-4%	-$29.2K	0.19%	151
2013 Q3	$724K	Sell	3,013 -172	-5%	-$38.5K	0.19%	153
2013 Q2	$683K	Buy	+3,185	New	+$681K	0.21%	138

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Investors Capital Advisory Services's BIIB Position: Q1 2016 in Review

Investors Capital Advisory Services sold out of Biogen (BIIB) in Q1 2016, closing a stake of 780 shares — an estimated $238K sold.

Investors Capital Advisory Services first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $1.12M in Q1 2015. 947 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

Investors Capital Advisory Services reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
Investors Capital Advisory Services sold 780 Biogen shares in Q1 2016, an estimated $238K.
Investors Capital Advisory Services first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
Investors Capital Advisory Services's Biogen position peaked at $1.12M in Q1 2015.
947 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Investors Capital Advisory Services's 13F filing for Q1 2016, filed 9 May 2016.